AVENTIS PHARMA S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 20284
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13156
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 58109
 
  
 
C07J STEROIDS491
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4257
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3366
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 26112
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2075
 
  
 
C07K PEPTIDES 20116
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 16109

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0042,941 CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERSDec 14, 16Feb 15, 18[A61K]
2017/0183,736 MUTATIONS OF THE PARKIN GENE, COMPOSITIONS, METHODS AND USESNov 04, 16Jun 29, 17[C12Q, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9540693 Mutations of the parkin gene, compositions, methods and usesAug 07, 14Jan 10, 17[C12Q, C12N, C07K]
9309210 Crystalline form of cabazitaxel and process for preparing the sameJun 11, 14Apr 12, 16[C07D]
9126969 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereofDec 18, 08Sep 08, 15[C07D]
8962021 Solid pharmaceutical composition comprising telithromycinAug 30, 13Feb 24, 15[A61K]
8927592 Antitumoral use of cabazitaxelApr 26, 12Jan 06, 15[A61K]
8852878 Method for identifying an antagonist of guanine nucleotide releasing factor 1Aug 03, 11Oct 07, 14[G01N]
8846959 Crystalline forms of dimethoxy docetaxel and methods for preparing the sameFeb 15, 13Sep 30, 14[C07D]
8835618 Mutations of the parkin geneAug 15, 11Sep 16, 14[C07H, C12Q, C12N]
8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesOct 05, 07Apr 29, 14[A61K]
8685705 Desmosterol-producing yeast strains and uses thereofMay 24, 12Apr 01, 14[C07H, C12P, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0331,717 CABAZITAXEL AND ITS USE FOR TREATING CANCERAbandonedMay 12, 16Nov 17, 16[A61J, A61K]
2015/0374,717 CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERSAbandonedSep 03, 15Dec 31, 15[A61K]
2015/0118,182 NOVEL ANTITUMORAL USE OF CABAZITAXELAbandonedDec 18, 14Apr 30, 15[A61K]
2015/0104,411 NOVEL ANTITUMORAL USE OF CABAZITAXELAbandonedDec 18, 14Apr 16, 15[A61K]
2014/0350,272 CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAMEAbandonedAug 06, 14Nov 27, 14[C07D]
2014/0350,273 PEDIATRIC USES OF CABAZITAXELAbandonedAug 07, 14Nov 27, 14[A61K]
2014/0127,202 ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECANAbandonedJan 13, 14May 08, 14[A61K]
2014/0073,698 PHARMACEUTICAL COMPOSITION COMPRISING KETOPROFENAbandonedNov 18, 13Mar 13, 14[A61K]
2014/0056,996 ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATINAbandonedAug 22, 13Feb 27, 14[A61K]
2014/0030,265 MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS METHODAbandonedJun 28, 13Jan 30, 14[A61K, C07K]
2013/0210,898 RECOMBINANT VIRUSES AND THEIR USE FOR TREATMENT OF ATHEROSCLEROSIS AND OTHER FORMS OF CORONARY ARTERY DISEASE AND METHOD, REAGENT, AND KIT FOR EVALUATING SUSCEPTIBILITY TO SAMEAbandonedFeb 08, 13Aug 15, 13[A61K]
2013/0184,205 ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOFAbandonedMar 04, 13Jul 18, 13[A61K]
8481487 Modified soluble FGF receptor Fc fusions methodExpiredJan 11, 12Jul 09, 13[A61K]
8431119 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseasesExpiredAug 22, 07Apr 30, 13[A61K, A01N, C12N]
2013/0101,524 SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERYAbandonedDec 12, 12Apr 25, 13[A61K]
2013/0102,565 SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPEDIC SURGERYAbandonedDec 12, 12Apr 25, 13[A61K]
2013/0102,566 SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS AND MAJOR BLEEDINGSAbandonedDec 12, 12Apr 25, 13[A61K]
2012/0322,759 SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPYAbandonedMay 11, 12Dec 20, 12[A61K, G06Q, A61P]
2012/0277,235 Compositions For Topical Application Having Androgenic ActionsAbandonedMar 30, 12Nov 01, 12[A61K, A61P]
8273548 Nucleic acids encoding a human PAP1 polypeptideExpiredMar 28, 06Sep 25, 12[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.